Search Results - "Patel, Shreyaskumar"

Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.

Authors: Nakazawa, Michael S Livingston, J Andrew Zarzour, Maria A et al.

Source: Rare Tumors. 8/4/2024, p1-9. 9p.

High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience.

Authors: Nasr, Lewis F. Zoghbi, Marianne Lazcano, Rossana et al.

Source: Cancers. May2024, Vol. 16 Issue 9, p1763. 17p.

Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.

Authors: Denu, Ryan A. Joseph, Cissimol P. Urquiola, Elizabeth S. et al.

Source: Cancers. May2024, Vol. 16 Issue 9, p1707. 16p.

Primary Intrathoracic Synovial Sarcoma: An Analysis of Outcomes of This Rare Disease.

Authors: Patel, Riddhi R. Bishop, Andrew J. Lazar, Alexander J. et al.

Source: Cancers. Mar2025, Vol. 17 Issue 5, p745. 15p.

Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?

Authors: Thirasastr, Prapassorn Sutton, Thomas L. Joseph, Cissimol P. et al.

Source: Cancers. Mar2024, Vol. 16 Issue 5, p904. 16p.

Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma.

Authors: Thirasastr, Prapassorn Lin, Heather Amini, Behrang et al.

Source: Cancer Medicine. Feb2023, Vol. 12 Issue 4, p4282-4293. 12p.

PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.

Authors: Parkes, Amanda Urquiola, Elizabeth Bhosale, Priya et al.

Source: Sarcoma. 6/1/2020, p1-6. 6p. 1 Color Photograph, 2 Charts, 2 Graphs.

TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature.

Authors: Ginn, Madison P. Denu, Ryan A. Ingram, Davis R. et al.

Source: Cancers. May2025, Vol. 17 Issue 9, p1441. 24p.

A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies.

Authors: Piha-Paul, Sarina A Dumbrava, Ecaterina E Nair, Binoj C et al.

Source: OncoTargets & Therapy. May2021, Vol. 14, p3037-3049. 13p.

Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.

Authors: Jones, Robin L. Herzog, Thomas J. Patel, Shreyaskumar R. et al.

Source: Cancer Medicine. Jun2021, Vol. 10 Issue 11, p3565-3574. 10p.

STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.

Authors: Subbiah, Vivek McMahon, Caitlin Patel, Shreyaskumar et al.

Source: Journal of Hematology & Oncology. 2015, Vol. 8 Issue 1, p1-7. 7p.

Abstract Author Index.

Source: Thyroid: official journal of the American Thyroid Association 2023 Supplement 1; Vol. 33.

Journal Info: Publisher: Mary Ann Liebert, Inc. ISSN: 1050-7256

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.

Authors: Jones, Robin L. Maki, Robert G. Patel, Shreyaskumar R. et al.

Source: Cancer (0008543X). 12/15/2019, Vol. 125 Issue 24, p4435-4441. 7p.

Current and Emerging Pharmacological Treatments for Gastrointestinal Stromal Tumour.

Authors: Ganjoo, Kristen N. Patel, Shreyaskumar

Source: Drugs. 2011, Vol. 71 Issue 3, p321-330.

URL: 60572778

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.

Authors: Roszik, Jason Wei-Lien Wang Livingston, John A. et al.

Source: Clinical Sarcoma Research. 6/15/2017, Vol. 7, p1-7. 7p.

Predictors of survival in patients with sarcoma admitted to the intensive care unit.

Authors: Gupta, Rohan Heshami, Neda Jay, Chouhan et al.

Source: Clinical Sarcoma Research. 7/19/2016, Vol. 6, p1-12. 12p.

Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma.

Authors: Joseph, Jason Wei-lien Wang Patnana, Madhavi et al.

Source: Clinical Sarcoma Research. 10/19/2015, Vol. 5, p1-6. 6p.

Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study.

Authors: Ravi, Vinod Subramaniam, Aparna Zheng, Jing et al.

Source: Cancer (0008543X). Sep2022, Vol. 128 Issue 18, p3383-3391. 9p.

ISPE20 Author Index.

Source: Pharmacoepidemiology and drug safety Oct2020 Supplement S3; Vol. 29.

Journal Info: Publisher: Wiley-Blackwell ISSN: 1053-8569

MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.

Authors: Conley, Anthony P. Wang, Wei-Lien Livingston, John A. et al.

Source: Cancers. May2019, Vol. 11 Issue 5, p677. 1p.